Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03410667 · ClinicalTrials.gov registry record · NA
Incontinence and Quality of Life in Children With Spina Bifida
A NA study of Spina Bifida and Myelomeningocele, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT03410667: Active NA study of Spina Bifida and Myelomeningocele, sponsored by Indiana University.
NCT03410667 is a NA study of Spina Bifida and Myelomeningocele that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 67 participants, above the 49-participant average among 16 other Spina Bifida trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03410667, a NA study of Spina Bifida and Myelomeningocele, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to develop an innovative, interactive tool for joint use by spina bifida patients and their urologists to identify patients interested in addressing their urinary and fecal incontinence and establish continence goal(s) they would like to achieve. To date, no such tool exists for use by spina bifida patients or urologists. This represents a major paradigm shift in the urologic care of pediatric SB patients. It will give children and families a voice in setting their personal goals for urinary and fecal incontinence, rather than relying on physicians' traditional clinical targets (e.g., absence of urinary incontinence, 4-hour dry interval). These traditional views fail to reflect the full patient experience of their ailment by underestimating symptoms and prioritizing only the most severe. This study represents the first time that such a process will be formalized before initiating urological therapy in children with SB (Aim 2). Additionally, this tool may help rule out interventions with a low chance of achieving desired goals and allow for a recalibration of unrealistic goals. The app will be useful for any child, regardless of urinary and fecal incontinence treatment history or underlying bladder pathology, as it will help describe personalized clinical treatment goals based on urinary incontinence, a characteristic all these patients share. This study will also capture the health-related quality of life (HRQOL) impact of urinary and fecal incontinence improvement regardless of the treatment, whether behavioral, medical or surgical, many of which are available to patients regardless of age. A systematic therapeutic goal-setting tool will help in bringing precision medicine to the SB population.
Primary Outcome
The primary outcome, SB-specific HRQOL, will be evaluated using the validated 10-item QUAlity of Life ASsessment in Children/Teenagers (QUALAS-C/T) questionnaire. Scores range from 0 to 100, with higher scores signifying better HRQOL.
Conditions Studied
Interventions
- BEHAVIORAL Phase One: Exploration
- BEHAVIORAL Phase Two: Creation
- BEHAVIORAL Phase Three: Reflection
- BEHAVIORAL Aim 3
Study Locations (1)
Indiana
- Riley Hospital for Children - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2019-12-01 |
| Est. Completion | 2026-03-15 |
| Phase | NA |
What the registry record for NCT03410667 still lists
NCT03410667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, above the 49-participant average among 16 other Spina Bifida trials with a reported enrollment target (37% higher).
The record links to 2 conditions, with Spina Bifida appearing as the primary indexed condition, and to 4 interventions - of which Phase One: Exploration is the first listed.
NCT03410667 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03410667 about?
NCT03410667 is a clinical study titled "Incontinence and Quality of Life in Children With Spina Bifida". This study aims to develop an innovative, interactive tool for joint use by spina bifida patients and their urologists to identify patients interested in addressing their urinary and fecal incontinence and establish continence goal(s) they would like to achieve. To date, no such tool exists for use ...
What is the current status of trial NCT03410667?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2019-12-01. Estimated completion is 2026-03-15.
What conditions does trial NCT03410667 study?
This clinical trial studies the following conditions: Spina Bifida, Myelomeningocele.
What interventions are being tested in trial NCT03410667?
The interventions under investigation include: Phase One: Exploration (BEHAVIORAL), Phase Two: Creation (BEHAVIORAL), Phase Three: Reflection (BEHAVIORAL), Aim 3 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03410667?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03410667 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spina Bifida
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03410667's enrollment target sits among peer trials
67 5th of 16 higher than 12 of 16 other Spina Bifida trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spina Bifida trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
RECRUITING · NA
-
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
RECRUITING · NA
-
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI